Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PANW vs GSK✓SelectedUSD · GSKPANW vs GSK performance historyLatest closeAs of+9.90%11/18
Stock and ETF performance explorer

PANW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+3,738.7%
GSK return
+112.3%
Excess return
+3,626.5%
Maximum drawdown
-48.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+9.9%-1.3%+11.2%+10.3%
7D+1.6%-3.1%+4.8%+2.4%
30D-2.0%-0.9%-1.1%-1.9%
3M-9.1%-4.2%-5.0%-8.4%
6M+37.3%-1.6%+38.9%+36.8%
YTD+84.5%+2.6%+81.9%+79.3%
1Y+69.1%+6.2%+62.9%+62.4%
3Y+174.6%+55.0%+119.6%+125.1%
5Y+292.2%+42.8%+249.4%+225.7%
10Y+1,164.0%+102.1%+1,061.9%+756.1%
All+3,738.7%+112.3%+3,626.5%+2,622.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling